Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kinesin family member 19B, pseudogene (KIF19BP) is a DNA segment in the human genome that closely resembles a functional kinesin gene, but due to accumulated mutations, it does not encode a functional protein. Pseudogenes like KIF19BP are evolutionarily derived from protein-coding genes, often through gene duplication or retrotransposition events, but have lost the ability to produce functional protein products. While most pseudogenes are biologically inactive, a small subset can have regulatory functions, such as acting as decoys for RNA molecules. However, there is no evidence that KIF19BP plays such a role. Pseudogenes can complicate genetic studies due to their sequence similarity to coding genes, sometimes confounding genetic diagnostics and PCR analyses[1][3][5]. Key points: - KIF19BP is not a receptor, enzyme, transporter, or otherwise considered a druggable or therapeutic target[3][5]. - As a *pseudogene*, it should not be confused with the functional *kinesin family member 19* (KIF19), a motor protein with established cellular roles. - The information for standard drug discovery/therapeutic target fields is not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kinesin family member 19B, pseudogene (KIF19BP).